Julia Szekeres-Bartho1, Beata Polgar. 1. Department of Medical Microbiology and Immunology, Medical School, Pecs University, H-7643 Pecs, Hungary. julia.szekeres@aok.pte.hu
Abstract
PROBLEM: The role of progesterone-dependent immunomodulation in the maintenance of normal pregnancy. METHODS: In vitro and in vivo data on the effect that progesterone and its mediator progesterone-induced blocking factor (PIBF) exert on the immune functions of pregnant women are reviewed, together with clinical findings. RESULTS: Activated pregnancy lymphocytes express progesterone receptors, which enable progesterone to induce a protein called PIBF. PIBF increases Th2 type cytokine production by signaling via a novel type of IL-4 receptor and activating the Jak/STAT pathway. PIBF inhibits phosholipase A2, thus reduces prostaglandin synthesis. PIBF inhibits perforin release in human decidual lymphocytes and reduces the deleterious effect of high NK activity on murine pregnancy. PIBF production is a characteristic feature of normal human pregnancy, and its concentration is reduced in threatened pregnancies. PIBF mRNA and protein are expressed in a variety of malignant tumors. Inhibition of PIBF synthesis increases survival rates of leukemic mice. CONCLUSION: Progesterone-induced blocking factor is produced by pregnancy lymphocytes and also by malignant tumors. The PIBF-induced Th2-dominant immune response is favorable during pregnancy but might facilitate tumor growth by suppressing local antitumor immune responses.
PROBLEM: The role of progesterone-dependent immunomodulation in the maintenance of normal pregnancy. METHODS: In vitro and in vivo data on the effect that progesterone and its mediator progesterone-induced blocking factor (PIBF) exert on the immune functions of pregnant women are reviewed, together with clinical findings. RESULTS: Activated pregnancy lymphocytes express progesterone receptors, which enable progesterone to induce a protein called PIBF. PIBF increases Th2 type cytokine production by signaling via a novel type of IL-4 receptor and activating the Jak/STAT pathway. PIBF inhibits phosholipase A2, thus reduces prostaglandin synthesis. PIBF inhibits perforin release in human decidual lymphocytes and reduces the deleterious effect of high NK activity on murine pregnancy. PIBF production is a characteristic feature of normal human pregnancy, and its concentration is reduced in threatened pregnancies. PIBF mRNA and protein are expressed in a variety of malignant tumors. Inhibition of PIBF synthesis increases survival rates of leukemicmice. CONCLUSION:Progesterone-induced blocking factor is produced by pregnancy lymphocytes and also by malignant tumors. The PIBF-induced Th2-dominant immune response is favorable during pregnancy but might facilitate tumor growth by suppressing local antitumor immune responses.
Authors: Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic Journal: Mayo Clin Proc Date: 2014-04 Impact factor: 7.616
Authors: Jason W Hoskins; Abdisamad Ibrahim; Mickey A Emmanuel; Sarah M Manmiller; Yinglun Wu; Maura O'Neill; Jinping Jia; Irene Collins; Mingfeng Zhang; Janelle V Thomas; Lauren M Rost; Sudipto Das; Hemang Parikh; Jefferson M Haake; Gail L Matters; Robert C Kurtz; William R Bamlet; Alison Klein; Rachael Stolzenberg-Solomon; Brian M Wolpin; Ronit Yarden; Zhaoming Wang; Jill Smith; Sara H Olson; Thorkell Andresson; Gloria M Petersen; Laufey T Amundadottir Journal: Hum Mol Genet Date: 2016-11-01 Impact factor: 6.150
Authors: Bihui Huang; Azure N Faucette; Michael D Pawlitz; Bo Pei; Joshua W Goyert; Jordan Zheng Zhou; Nadim G El-Hage; Jie Deng; Jason Lin; Fayi Yao; Robert S Dewar; Japnam S Jassal; Maxwell L Sandberg; Jing Dai; Montserrat Cols; Cong Shen; Lisa A Polin; Ronald A Nichols; Theodore B Jones; Martin H Bluth; Karoline S Puder; Bernard Gonik; Nihar R Nayak; Elizabeth Puscheck; Wei-Zen Wei; Andrea Cerutti; Marco Colonna; Kang Chen Journal: Nat Med Date: 2016-12-05 Impact factor: 53.440